Mrs. Brenda Jean Fowler, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 514 W Main St, Sac City, IA 50583 Phone: 712-662-7146 |
Michael Christoffersen, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 514 W Main St, Sac City, IA 50583 Phone: 712-662-7146 |
Marcy Wagner, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 W Main St, Sac City, IA 50583 Phone: 712-662-8165 |
Martha Huser Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 W. Main Str, Sac City, IA 50583 Phone: 712-662-8165 Fax: 888-498-1628 |
Makayla Ernst Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 W Main St, Sac City, IA 50583 Phone: 712-662-8165 |
News Archive
Spraying malaria-transmitting mosquitoes with a genetically modified fungus can kill the malaria parasite without harming the mosquito, potentially reducing malaria transmission to humans, according to a new study published in the journal Science. Funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, the study was led by Raymond J. St. Leger, Ph.D., of the University of Maryland, College Park.
A simple drug, given to children with severe malaria before they reach hospital, has the potential to save many lives, say researchers in this week's BMJ.
InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company will be exhibiting at LUMEN 2010, the world's premier ST-elevation myocardial infarction (STEMI) meeting, to be held February 25-27, 2010 at the Loews Miami Beach Hotel in Miami Beach, Florida. The 9th Annual LUMEN meeting is an educational symposium providing updates from world-renowned experts in key areas of interventional cardiology and vascular intervention.
It's no secret that going without sleep can affect people's mood, but a new study shows it does not interfere with their ability to evaluate emotional situations.
BG Medicine today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price of $7.00 per share, before underwriting discounts and commissions. All shares are being sold by the Company.
› Verified 5 days ago